5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | NEUTRAL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.69▼ | 1.67▲ | 1.67▲ | 1.71▼ | 1.74▼ |
MA10 | 1.67▲ | 1.66▲ | 1.67▲ | 1.80▼ | 1.80▼ |
MA20 | 1.66▲ | 1.67▲ | 1.69▼ | 1.77▼ | 2.06▼ |
MA50 | 1.68▲ | 1.71▼ | 1.79▼ | 1.74▼ | 18.98▼ |
MA100 | 1.69▼ | 1.80▼ | 1.78▼ | 2.11▼ | N/A |
MA200 | 1.79▼ | 1.76▼ | 1.71▼ | 16.71▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | 0.005▲ | 0.005▲ | -0.013▼ | 1.038▲ |
RSI | 51.841▲ | 48.990▼ | 44.734▼ | 44.888▼ | 27.710▼ |
STOCH | 40.152 | 35.029 | 32.882 | 26.734 | 39.521 |
WILL %R | -63.636 | -58.333 | -58.333 | -83.133▼ | -68.132 |
CCI | 35.105 | 53.552 | -6.061 | -79.839 | -28.051 |
Friday, June 13, 2025 08:59 AM
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune ...
|
Wednesday, May 28, 2025 06:07 AM
I n a turbulent market environment, Homology Medicines Inc 's stock (NASDAQ:QTTB) has been under significant pressure, reaching a 52-week low of $2.95. According to InvestingPro data, the company ...
|
Sunday, May 04, 2025 06:10 PM
Get the latest news on Q32 Bio stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Q32 Bio performance ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 1.68 | 1.85 | 1.63 | 1.67 | 154,641 |
12/06/25 | 1.69 | 1.74 | 1.68 | 1.70 | 57,413 |
11/06/25 | 1.74 | 1.81 | 1.68 | 1.70 | 70,345 |
10/06/25 | 1.83 | 1.85 | 1.65 | 1.675 | 111,714 |
09/06/25 | 1.98 | 1.98 | 1.78 | 1.82 | 100,693 |
06/06/25 | 1.90 | 1.92 | 1.82 | 1.90 | 108,447 |
05/06/25 | 1.94 | 1.9699 | 1.82 | 1.84 | 172,778 |
04/06/25 | 1.92 | 2.015 | 1.89 | 1.93 | 331,962 |
03/06/25 | 1.80 | 1.97 | 1.799 | 1.92 | 91,249 |
02/06/25 | 1.75 | 1.90 | 1.7306 | 1.83 | 89,509 |
|
|
||||
|
|
||||
|
|